GPGiora Pillar

Giora Pillar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Giora Pillar has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 August 2013
      • Vol. 15  (8) , 419-23

    Double-blind placebo and active (caffeine) controlled study to examine the effects of the herbal nutritional supplement beverage "Wake up" on vigilance and function after lunch.

    by Ola Kassis, Neriel Katz, Sarit Ravid, Giora Pillar

    Post-lunch dip is a well-known phenomenon that results in a substantial deterioration in function and productivity after lunch. To assess whether a new herbal-based potentially wake-promoting beverage is effective in counteracting somnolence and reduced post-lunch performance. Thirty healthy volunteers were studied on three different days at the sleep clinic. On each visit they ate a standard lunch at noontime, followed by a drink of "Wake up," 50 mg caffeine, or a placebo in a cross-over double-blind regimen. At 30 and 120 minutes post-drinking, they underwent a battery of tests to determine the effects of the beverage. These included: a) a subjective assessment of alertness and performance based on a visual analog scale, and b) objective function tests: the immediate word recall test, the digit symbol substitution test (DSST), and hemodynamic measurements. The results of the three visits were compared using one-way analysis of variance, with P < 0.05 considered statistically significant. In all performance tests, subjective vigilance and effectiveness assessment, both Wake up and caffeine were significantly superior to placebo 30 minutes after lunch. However, at 2 hours after lunch, performance had deteriorated in those who drank the caffeine-containing drink, while Wake up was superior to both caffeine and placebo. Blood pressure and pulse were higher 2 hours after caffeine ingestion, compared to both Wake up and placebo. These results suggest that a single dose of Wake up is effective in counteracting the somnolence and reduced performance during the post-lunch hours. In the current study it had no adverse hemodynamic consequences.


  • Open Access

    The SomnuSeal Oral Mask Is Reasonably Tolerated by Otherwise CPAP Noncompliant Patients with OSA

    by N. Katz, Y. Adir, T. Etzioni, E. Kurtz, G. Pillar

    Compliance with CPAP is the major limiting factor in treating patients with OSA. The novel SomnuSeal mask is an oral self-adaptable mask located between the teeth and the lips ensuring that there are no air leaks or skin abrasions. Fifty patients withAHI>20, who failed previous CPAP trials, were asked to sleep with the mask for one month. In all patients, the mask was connected to an AutoPAP machine with a heated humidifier. Efficacy, convenience, and compliance (average usage for 4 or more hours per night) were monitored. Fifty patients (41 m and 9 f, mean age57±12years, BMI33.6±4.9 kg/m2, and AHI47±23/h) participated. Eleven were classified as compliant (average mask usage of 26 nights, 4.7 hours per night), five were only partially compliant (average usage of 13 nights, 2.9 hours per night), and 34 could not comply with it. In all patients who slept with it, the efficacy (assessed by residual AHI derived from the CPAP device) was good with an AHI of less than 8/hour. Interestingly, the required optimal pressure decreased from an average of 9.3 cmH2O to 4.6 cmH2O. The SomnuSeal oral interface is effective and may result in converting noncompliant untreated patients with OSA into well-treated ones.


  • Acoustic Snoring Analysis Can Provide Important Information in OSA Diagnosis

    by Giora Pillar, Tamar Etzioni, Neriel Katz

    S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.


  • Open Access

    Sleep, Sleep Apnea, Diabetes, and the Metabolic Syndrome: The Role of Treatment

    by Tamar Etzioni, Giora Pillar

    Studies from the last decade have demonstrated the great importance of sleep in metabolic control in general, and glycemic control in particular. It appears that there is a clear U-shaped association between sleep duration and the risk for diabetes, with substantial increased risk of diabetes in people sleeping less than 6 hours per night or more than 8 hours per night.1 However, these epidemiological studies do not prove causality. Just as sleep periods either too short or too long may contribute to the development of diabetes, diabetes may result in fragmented sleep that is too short or sleep that is deeper and longer (especially if hypoglycemia occurs).2 Thus, there seems to be complex relations between sleep and diabetes. Interventional experiments may shed light on the directionality of these effects. Experimental sleep deprivation in healthy volunteers resulted in insulin resistance, which normalized following recovery sleep.3 The most common cause for insulin resistance in patients with hypersomnolence is the obstructive sleep apnea (OSA) syndrome.


  • Sublingual Flumazenil for the Residual Effects of Hypnotics: Zolpidem and Brotizolam

    by Neriel Katz, Giora Pillar, Eli Peled, Adi Segev, Nir Peled

    Residual morning drowsiness is a frequent side effect of hypnotics. This study examined the safety and efficacy of sublingual Flumazenil in reversing the residual hypnotic effect. A double-blind, placebo-controlled, randomized crossover study with 20 healthy subjects who slept for 1.5 hours following sleep induction was conducted. Upon awakening, they underwent neurocognitive tests including immediate word recall test (iWRT), Digit Symbol Substitution Test (DSST), and mood/performance questionnaires. They were then treated by Flumazenil or placebo and were reevaluated after 20 and 60 minutes. A week later, the same procedures were performed (placebo/Flumazenil accordingly). All 20 volunteers completed the study. Flumazenil was superior to placebo by 59% to 93% (P < .05-.001) in improving performance in the various neurocognitive tasks. Subjects reported a significant improvement in vigilance with Flumazenil, both at 20 minutes and 60 minutes. iWRT improved with Flumazenil vs placebo at 20 minutes (4.2 ± 0.8 vs 1.3 ± 0.9 words, P < .005) and 60 minutes (5.4 ± 1.1 vs 1.2 ± 1.2 words, P < .02). Sublingual administration of Flumazenil is safe and effective in reversing the hypnotic effects of Zolpidem and Brotizolam. This may offer a comprehensive and safer treatment for insomniac patients.


  • Sleep Staging Based on Autonomic Signals: A Multi-Center Validation Study

    by Jan Hedner, David P. White, Atul Malhotra, Sarah Herscovici, Stephen D. Pittman, Ding Zou, Ludger Grote, Giora Pillar

    One of the most important caveats of ambulatory devices is the inability to record and stage sleep. We assessed an algorithm determining 4 different stages: wake, light sleep, deep sleep, and REM sleep using signals derived from the portable monitor Watch-PAT100 (PAT recorder). Participants (38 normal subjects and 189 patients with obstructive sleep apnea [OSA]) underwent simultaneous overnight recordings with polysomnography (PSG) and the PAT recorder in a study originally designed to assess the accuracy of the PAT recorder in diagnosing OSA. Light/deep sleep and REM sleep from the PAT recorder recording were automatically scored based on features extracted from time series of peripheral arterial tone amplitudes and inter pulse periods. The PSG scored sleep stages 1 and 2 were classified as light sleep for epoch-by-epoch comparisons. The overall agreement in detecting light/deep and REM sleep were 88.6% ± 5.9% and 88.7% ± 5.5%, respectively. There was a good agreement between PSG and the PAT recorder in quantifying sleep efficiency (78.4% ± 9.9% vs. 78.8% ± 13.4%), REM latency (237 ± 148 vs. 225 ± 159 epochs), and REM percentage (14.4% ± 6.5% vs. 19.3% ± 8.7%). OSA severity did not affect the sensitivity and specificity of the algorithm. The Cohen κ coefficient for detecting all sleep stages: sleep from wake, REM from NREM sleep, and deep from light sleep were 0.48, 0.55, 0.59, and 0.46, respectively. Analysis of autonomic signals from the PAT recorder can detect sleep stages with moderate agreement to more standard techniques in normal subjects and OSA patients. This novel algorithm may provide insights on sleep and sleep architecture when applying the PAT recorder for OSA diagnosis.


  • Organization of the first edition

    by Jaime M. Monti, Andrew A. Monjan, Sonia Ancoli-Israel, Ragnar Asplund, Michel Billiard, Theresa M. Buckley, Rohit Budhiraja, Robert N. Butler, Daniel J. Buysse, Scott S. Campbell, et al.

    Sleep disorders cause considerable morbidity and distress in the aging population. By highlighting the clinical diagnosis and management of sleep disorders, this volume provides a valuable resource for all those involved in health care of older individuals. The changes in sleep patterns that occur during normal aging are described, followed by authoritative chapters on the presentation of various age-related sleep disorders. The book deals with the range of therapeutic measures available for managing these disorders and gives insight to potential areas of research that have emerged in the last few years, such as the study of circadian rhythms in later life, sleep patterns associated with co-morbidities and the use of quality-of-life measurement tools to determine sleep quality as we age. This volume is relevant to sleep disorders specialists, psychiatrists, geriatricians and gerontologists, and any professionals and researchers working in the interdisciplinary areas of sleep and aging.

  • Preface

    by Jaime M. Monti, Andrew A. Monjan, Sonia Ancoli-Israel, Ragnar Asplund, Michel Billiard, Theresa M. Buckley, Rohit Budhiraja, Robert N. Butler, Daniel J. Buysse, Scott S. Campbell, et al.

    Sleep disorders cause considerable morbidity and distress in the aging population. By highlighting the clinical diagnosis and management of sleep disorders, this volume provides a valuable resource for all those involved in health care of older individuals. The changes in sleep patterns that occur during normal aging are described, followed by authoritative chapters on the presentation of various age-related sleep disorders. The book deals with the range of therapeutic measures available for managing these disorders and gives insight to potential areas of research that have emerged in the last few years, such as the study of circadian rhythms in later life, sleep patterns associated with co-morbidities and the use of quality-of-life measurement tools to determine sleep quality as we age. This volume is relevant to sleep disorders specialists, psychiatrists, geriatricians and gerontologists, and any professionals and researchers working in the interdisciplinary areas of sleep and aging.

  • Foreword by Robert N. Butler

    by Robert N. Butler, Jaime M. Monti, Andrew A. Monjan, Sonia Ancoli-Israel, Ragnar Asplund, Michel Billiard, Theresa M. Buckley, Rohit Budhiraja, Daniel J. Buysse, Scott S. Campbell, et al.

    Sleep disorders cause considerable morbidity and distress in the aging population. By highlighting the clinical diagnosis and management of sleep disorders, this volume provides a valuable resource for all those involved in health care of older individuals. The changes in sleep patterns that occur during normal aging are described, followed by authoritative chapters on the presentation of various age-related sleep disorders. The book deals with the range of therapeutic measures available for managing these disorders and gives insight to potential areas of research that have emerged in the last few years, such as the study of circadian rhythms in later life, sleep patterns associated with co-morbidities and the use of quality-of-life measurement tools to determine sleep quality as we age. This volume is relevant to sleep disorders specialists, psychiatrists, geriatricians and gerontologists, and any professionals and researchers working in the interdisciplinary areas of sleep and aging.

  • Plate section

    by Jaime M. Monti, Andrew A. Monjan, Sonia Ancoli-Israel, Ragnar Asplund, Michel Billiard, Theresa M. Buckley, Rohit Budhiraja, Robert N. Butler, Daniel J. Buysse, Scott S. Campbell, et al.

    Sleep disorders cause considerable morbidity and distress in the aging population. By highlighting the clinical diagnosis and management of sleep disorders, this volume provides a valuable resource for all those involved in health care of older individuals. The changes in sleep patterns that occur during normal aging are described, followed by authoritative chapters on the presentation of various age-related sleep disorders. The book deals with the range of therapeutic measures available for managing these disorders and gives insight to potential areas of research that have emerged in the last few years, such as the study of circadian rhythms in later life, sleep patterns associated with co-morbidities and the use of quality-of-life measurement tools to determine sleep quality as we age. This volume is relevant to sleep disorders specialists, psychiatrists, geriatricians and gerontologists, and any professionals and researchers working in the interdisciplinary areas of sleep and aging.